UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 40-F
|
[Check
One]
|
|
|
|
|
o
|
|
Registration
Statement Pursuant to Section 12 of the
|
|
|
|
|
Securities
Exchange Act of 1934
|
|
|
|
|
|
|
|
x
|
|
Annual Report
Pursuant to Section 13(a) or 15(d) of the
|
|
|
|
|
Securities
Exchange Act of 1934
|
|
|
For
the fiscal year ended:
September 30, 2007
|
|
Commission File Number: 0-30860
|
Axcan Pharma Inc.
(Exact name of Registrant as specified in its charter)
N/A
(Translation of Registrant’s name into English (if applicable))
Canada
(Province or other jurisdiction of incorporation or organization)
5122
(Primary Standard Industrial Classification Code Number (if
applicable))
N/A
(I.R.S. Employer Identification Number (if applicable))
597 Laurier Blvd., Mont St-Hilaire, Quebec, Canada J3H 6C4 (450)
467-5138
(Address and telephone number of Registrant’s principal executive
offices)
CT Corporation System, 111 8th Avenue, 15th Floor, New York, New York,
10011 (212) 894-8700
(Name, address (including zip code) and telephone number)
(including area code of agent for service in the United States)
Securities
registered or to be registered pursuant to Section 12(b) of the Act.
|
Title of each class
|
|
Name of each exchange on which registered
|
|
Common Shares
|
|
The NASDAQ Stock Market, LLC
|
Securities
registered or to be registered pursuant to Section 12(g) of the Act.
Common Shares
(Title of Class)
Securities
for which there is a reporting obligation pursuant to Section 15(d) of
the Act.
Common Shares
(Title of Class)
For
annual reports, indicate by check mark the information filed with this Form:
x
Annual information form
x
Audited annual financial statements
Indicate
the number of outstanding shares of each of the issuer’s classes of capital or
common stock as of the close of the period covered by the annual report.
Indicate
by check mark whether the Registrant by filing the information contained in
this Form is also thereby furnishing the information to the Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934
(the
“Exchange Act”
). If “Yes”
is marked, indicate the filing number assigned to the Registrant in connection
with such Rule.
Indicate
by check mark whether the Registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Exchange Act during the
preceding 12 months (or for such shorter period that the Registrant was
required to file such reports) and (2) has been subject to such filing
requirements for the past 90 days.
**********
Registrant
undertakes to make available, in person or by telephone, representatives to
respond to inquiries made by the Commission staff, and to furnish promptly,
when requested to do so by the Commission staff, information relating to: the
securities registered pursuant to Form 40-F; the securities in relation to
which the obligation to file an annual report on Form 40-F arises; or
transactions in said securities.